^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MultiTAA T cell therapy

i
Associations
Company:
Baylor College of Medicine, Marker Therap
Drug class:
MAGE-A4 inhibitor, NY ESO 1 inhibitor, Survivin inhibitor, PRAME inhibitor, SSX2 inhibitor, Tumor-associated antigen inhibitor
Related drugs:
Associations
Phase 1
Baylor College of Medicine
Active, not recruiting
Last update posted :
10/26/2023
Initiation :
02/01/2016
Primary completion :
10/29/2019
Completion :
10/01/2024
CD8 • CD4 • MME
|
MultiTAA T cell therapy
Phase 1
Baylor College of Medicine
Recruiting
Last update posted :
06/19/2023
Initiation :
02/01/2016
Primary completion :
04/01/2024
Completion :
02/01/2026
KIT • WT1 • CD33 • ANPEP
|
MultiTAA T cell therapy